CRIS Current Research Information System

SIRICO, MARIANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.013
NA - Nord America 384
EU - Europa 293
SA - Sud America 26
AF - Africa 25
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.743
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 363
CN - Cina 298
SG - Singapore 291
VN - Vietnam 192
IT - Italia 117
HK - Hong Kong 81
KR - Corea 60
FR - Francia 40
NL - Olanda 39
IN - India 28
DE - Germania 27
JP - Giappone 19
FI - Finlandia 18
BR - Brasile 16
CI - Costa d'Avorio 13
GB - Regno Unito 11
CA - Canada 9
MX - Messico 9
AT - Austria 8
ID - Indonesia 8
BD - Bangladesh 6
PL - Polonia 6
SC - Seychelles 6
CH - Svizzera 5
AR - Argentina 4
ES - Italia 4
PH - Filippine 4
RU - Federazione Russa 4
TH - Thailandia 4
BE - Belgio 3
IE - Irlanda 3
AE - Emirati Arabi Uniti 2
CO - Colombia 2
EG - Egitto 2
GH - Ghana 2
IQ - Iraq 2
JO - Giordania 2
MY - Malesia 2
SA - Arabia Saudita 2
TW - Taiwan 2
UA - Ucraina 2
UZ - Uzbekistan 2
AU - Australia 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
CL - Cile 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
GR - Grecia 1
GT - Guatemala 1
IL - Israele 1
JM - Giamaica 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
MA - Marocco 1
NG - Nigeria 1
NP - Nepal 1
PK - Pakistan 1
PY - Paraguay 1
QA - Qatar 1
RO - Romania 1
SE - Svezia 1
TR - Turchia 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
YE - Yemen 1
Totale 1.743
Salva come PNG Salva come JPEG
Città #
Singapore 181
Hefei 152
San Jose 101
Hong Kong 73
Seoul 56
Dallas 52
Hanoi 49
Ho Chi Minh City 42
Council Bluffs 34
Ashburn 26
Lauterbourg 25
Los Angeles 25
Amsterdam 24
Milan 20
Santa Clara 20
Beijing 17
Bengaluru 16
Bologna 16
Tokyo 16
Abidjan 13
Helsinki 10
Haiphong 9
Lappeenranta 8
Boardman 7
Rome 7
Chicago 6
Da Nang 6
Falkenstein 6
Jakarta 6
Buffalo 5
Frankfurt am Main 5
Guangzhou 5
Modena 5
Munich 5
Mexico City 4
New York 4
Nuremberg 4
Quincy 4
Ravenna 4
Shanghai 4
Zurich 4
Bắc Giang 3
Castel Maggiore 3
Des Moines 3
Dublin 3
Huizhou 3
Monzuno 3
New Delhi 3
Ninh Bình 3
São Paulo 3
Thái Nguyên 3
Vienna 3
Warsaw 3
Acalanes Ridge 2
Accra 2
Alghero 2
Amman 2
Bagnacavallo 2
Bắc Ninh 2
City of London 2
Düsseldorf 2
Genoa 2
Hải Dương 2
London 2
Montreal 2
Mumbai 2
North Charleston 2
Orem 2
Osaka 2
Ottawa 2
Palermo 2
Perugia 2
Phoenix 2
Qingdao 2
Quận Bình Thạnh 2
Reggio Emilia 2
Roccalumera 2
San Francisco 2
Spinea 2
Tainan 2
Tashkent 2
Tongling 2
Trani 2
Trevi 2
Tân Tiến 2
Wroclaw 2
Zhengzhou 2
Ân Thi 2
Al Mansurah 1
Almaty 1
Angeles City 1
Apodaca 1
Araguaiana 1
Asunción 1
Baghdad 1
Baie-D'Urfé 1
Bangkok 1
Bartlett 1
Bebedouro 1
Berazategui 1
Totale 1.194
Salva come PNG Salva come JPEG
Nome #
Cell-Free DNA Fragmentomics: A Promising Biomarker for Diagnosis, Prognosis and Prediction of Response in Breast Cancer 164
Oligometastatic breast cancer and metastasis-directed treatment: an aggressive multimodal approach to reach the cure 150
Neoadjuvant endocrine therapy for luminal breast tumors: State of the art, challenges and future perspectives 143
Circulating inflammatory cells in patients with metastatic breast cancer: Implications for treatment 128
Locoregional treatment of de novo stage IV breast cancer in the era of modern oncology 119
Navigating the complexity of PI3K/AKT pathway in HER-2 negative breast cancer: biomarkers and beyond 116
Potential Impact of Preoperative Circulating Biomarkers on Individual Escalating/de-Escalating Strategies in Early Breast Cancer 112
Real-world effectiveness comparison of first-line palbociclib, ribociclib or abemaciclib plus endocrine therapy in advanced HR-positive/HER2-negative BC patients: results from the multicenter PALMARES-2 study 94
Current State and Future Challenges for PI3K Inhibitors in Cancer Therapy 82
Comparative analysis of Denosumab and Zoledronic acid in advanced breast cancer patients receiving CDK4/6 inhibitors 68
Next-generation sequencing-based evaluation of the actionable landscape of genomic alterations in solid tumors: the "MOZART" prospective observational study 61
Local treatment for oligoprogressive metastatic sites of breast cancer: efficacy, toxicities and future perspectives 54
Immune system and angiogenesis-related potential surrogate biomarkers of response to everolimus-based treatment in hormone receptor-positive breast cancer: an exploratory study 48
ROLE OF HPV VACCINATION AFTER CARCINOMA IN SITU OF CERVIX UTERI (CIN) IN REAL-WORLD PATIENTS 47
An update on antibody–drug conjugates in urothelial carcinoma: state of the art strategies and what comes next 46
Pharmacological Prevention in Breast Cancer: Current Evidence, Challenges, and Future Directions 45
Implications of hormonal carcinogenesis for transgender and gender-diverse people undergoing gender-affirming hormone therapy: an up-to-date review 45
Hormonal Therapy For Endometriosis And The Risk Of Endometriosis-Associated Gynecologic Cancers: A Propensity Score-Adjusted Real-World Data Study 36
Early Changes of the Standardized Uptake Values (SUVmax) Predict the Efficacy of Everolimus-Exemestane in Patients with Hormone Receptor-Positive Metastatic Breast Cancer 33
Canakinumab as treatment for COVID-19-related pneumonia: A prospective case-control study 32
Cancer management during the COVID-19 world pandemic 28
ΔKi67 proliferation index as independent predictive and prognostic factor of outcome in luminal breast cancer: data from neoadjuvant letrozole-based treatment 26
Corrigendum to “Neoadjuvant endocrine therapy for luminal breast tumors: State of the art, challenges and future perspectives” [Crit. Rev. Oncol./Hematol. 181 (2023) 103900] (Critical Reviews in Oncology / Hematology (2023) 181, (S1040842822003249), (10.1016/j.critrevonc.2022.103900)) 24
Impact of BMI on the outcome of metastatic breast cancer patients treated with everolimus: a retrospective exploratory analysis of the BALLET study 24
Hallmarks of Appetite: A Comprehensive Review of Hunger, Appetite, Satiation, and Satiety 23
Advances in anti-BRAF therapies for lung cancer 21
Corrigendum to “Navigating the complexity of PI3K/AKT pathway in HER-2 negative breast cancer: Biomarkers and beyond” [Crit. Rev. Oncol./Hematol. 200C (2024) 104404](S1040842824001471)(10.1016/j.critrevonc.2024.104404) 18
Efficacy of extended aromatase inhibitors for hormone-receptor-positive breast cancer: A literature-based meta-analysis of randomized trials 17
Totale 1.804
Salva come PNG Salva come JPEG
Categoria #
all - tutte 3.810
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.810
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202435 0 0 0 0 0 0 6 1 12 12 2 2
2024/2025285 10 23 19 25 20 18 9 19 1 17 38 86
2025/20261.484 68 127 237 147 121 60 242 94 276 112 0 0
Totale 1.804